An updated meta-analysis on the association of TGF-β1 gene promoter -509C/T polymorphism with colorectal cancer risk

Cytokine

Volumn 61, Issue 1, 2013, Pages 181-187

  Wang, Yadong ^a,c   Yang, Haiyan ^b   Li, Li ^a   Xia, Xiangqun ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b ZHENGZHOU UNIVERSITY   (China)

^c UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Colorectal cancer; Genetic polymorphism; Meta analysis; TGF 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ALLELE; AMERICAN; ARTICLE; CANCER RISK; CAUCASIAN; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC GROUP; GENE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; TRANSFORMING GROWTH FACTOR BETA1 GENE;

ALLELES; COLORECTAL NEOPLASMS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK; RISK FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84869884733     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.09.014     Document Type: Article

References (44)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012, 62:10-29.
3. Chan A.T., Giovannucci E.L. Primary prevention of colorectal cancer. Gastroenterology 2010, 138(2029-43):e10.
4. Chan D.S., Lau R., Aune D., Vieira R., Greenwood D.C., Kampman E., et al. Red and processed meat and colorectal cancer incidence. meta-analysis of prospective studies. PLoS ONE 2011, 6:e20456.
5. Ning Y., Wang L., Giovannucci E.L. A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies. Obes Rev 2010, 11:19-30.
6. Botteri E., Iodice S., Raimondi S., Maisonneuve P., Lowenfels A.B. Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology 2008, 134:388-395.
7. Cho E., Smith-Warner S.A., Ritz J., van den Brandt P.A., Colditz G.A., Folsom A.R., et al. Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med 2004, 140:603-613.
8. Houlston R.S., Webb E., Broderick P., Pittman A.M., Di Bernardo M.C., Lubbe S., et al. Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet 2008, 40:1426-1435.
9. Tomlinson I., Webb E., Carvajal-Carmona L., Broderick P., Kemp Z., Spain S., et al. A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet 2007, 39:984-988.
10. Tomlinson I.P., Webb E., Carvajal-Carmona L., Broderick P., Howarth K., Pittman A.M., et al. A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet 2008, 40:623-630.
11. Zanke B.W., Greenwood C.M., Rangrej J., Kustra R., Tenesa A., Farrington S.M., et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet 2007, 39:989-994.
12. Niittymaki I., Tuupanen S., Li Y., Jarvinen H., Mecklin J.P., Tomlinson I.P., et al. Systematic search for enhancer elements and somatic allelic imbalance at seven low-penetrance colorectal cancer predisposition loci. BMC Med Genet 2011, 12:23.
13. Massague J. TGFbeta in cancer. Cell 2008, 134:215-230.
14. Amirghofran Z., Jalali S.A., Ghaderi A., Hosseini S.V. Genetic polymorphism in the transforming growth factor beta1 gene (-509 C/T and -800 G/A) and colorectal cancer. Cancer Genet Cytogenet 2009, 190:21-25.
15. Grainger D.J., Heathcote K., Chiano M., Snieder H., Kemp P.R., Metcalfe J.C., et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 1999, 8:93-97.
16. Silverman E.S., Palmer L.J., Subramaniam V., Hallock A., Mathew S., Vallone J., et al. Transforming growth factor-beta1 promoter polymorphism C-509T is associated with asthma. Am J Respir Crit Care Med 2004, 169:214-219.
17. Chung S.J., Kim J.S., Jung H.C., Song I.S. Transforming growth factor-[beta]1 -509T reduces risk of colorectal cancer, but not adenoma in Koreans. Cancer Sci 2007, 98:401-404.
18. Zhang Y., Liu B., Jin M., Ni Q., Liang X., Ma X., et al. Genetic polymorphisms of transforming growth factor-beta1 and its receptors and colorectal cancer susceptibility: a population-based case-control study in China. Cancer Lett. 2009, 275:102-108.
19. Slattery M.L., Herrick J.S., Lundgreen A., Wolff R.K. Genetic variation in the TGF-beta signaling pathway and colon and rectal cancer risk. Cancer Epidemiol Biomarkers Prev 2011, 20:57-69.
20. Wei L., Chen F., Tan Z., Chen H. Association of TGF-β1 gene polymorphism with colorectal cancer. Tumor 2007, 27:383-405.
21. Crivello A., Giacalone A., Vaglica M., Scola L., Forte G.I., Macaluso M.C., et al. Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma. Ann NY Acad Sci 2006, 1089:98-103.
22. Macarthur M., Sharp L., Hold G.L., Little J., El-Omar E.M. The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland. Cancer Epidem Biomar Prev 2005, 14:1613-1618.
23. Saltzman B.S., Yamamoto J.F., Decker R., Yokochi L., Theriault A.G., Vogt T.M., et al. Association of genetic variation in the transforming growth factor beta-1 gene with serum levels and risk of colorectal neoplasia. Cancer Res 2008, 68:1236-1244.
24. Wu G.Y., Hasenberg T., Magdeburg R., Bonninghoff R., Sturm J.W., Keese M. Association between EGF, TGF-beta1, VEGF gene polymorphism and colorectal cancer. World J Surg 2009, 33:124-129.
25. Fang F., Yu L., Zhong Y., Yao L. TGFB1 509 C/T polymorphism and colorectal cancer risk: a meta-analysis. Med Oncol 2010, 27:1324-1328.
26. Li M., Yuan J., Li H., Zou Q., Liu Y., Yang P. Meta-analysis of TGF-β1-509C/T gene polymorphisms and colorectal cancer. J Med Postgrad 2011, 24:803-807.
27. Qi P., Ruan C.P., Wang H., Zhou F.G., Zhao Y.P., Gu X., et al. 509C>T polymorphism in the TGF-beta1 gene promoter is not associated with susceptibility to and progression of colorectal cancer in Chinese. Colorectal Dis 2010, 12:1153-1158.
28. Wu H., Fan Y., Liu W., He X., Zhu G., Zhu Z., et al. Transforming growth factor-beta 1 gene C-509T polymorphism and genetic susceptibility to colorectal cancer. World Chin J Digest 2008, 16:4020-4023.
29. Yu Y., Chen C. Association of transforming growth factor beta 1 gene polymorphisms with colorectal cancer. J Clin Intern Med 2010, 27:490-493.
30. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
31. Egger M., Davey Smith G, Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
32. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
33. Lichtenstein P., Holm N.V., Verkasalo P.K., Iliadou A., Kaprio J., Koskenvuo M., et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000, 343:78-85.
34. Calvert P.M., Frucht H. The genetics of colorectal cancer. Ann Intern Med 2002, 137:603-612.
35. Dahabreh I.J., Linardou H., Bouzika P., Varvarigou V., Murray S. TP53 Arg72Pro polymorphism and colorectal cancer risk: a systematic review and meta-analysis. Cancer Epidem Biomar Prev 2010, 19:1840-1847.
36. Dunning A.M., Ellis P.D., McBride S., Kirschenlohr H.L., Healey C.S., Kemp P.R., et al. A transforming growth factorbeta1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Res 2003, 63:2610-2615.
37. Jin G., Wang L., Chen W., Hu Z., Zhou Y., Tan Y., et al. Variant alleles of TGFB1 and TGFBR2 are associated with a decreased risk of gastric cancer in a chinese population. Int J Cancer 2007, 120:1330-1335.
38. Vishnoi M., Pandey S.N., Modi D.R., Kumar A., Mittal B. Genetic susceptibility of epidermal growth factor+61A>G and transforming growth factor beta 1 -509C>T gene polymorphisms with gallbladder cancer. Hum Immunol 2008, 69:360-367.
39. Wei Y.S., Zhu Y.H., Du B., Yang Z.H., Liang W.B., Lv M.L., et al. Association of transforming growth factor-beta1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma. Clin Chim Acta 2007, 380:165-169.
40. Coban S., Yuksel O., Kockar M.C., Koklu S., Basar O., Tutkak H., et al. The significance of serum transforming growth factor beta 1 in detecting of gastric and colon cancers. Hepatogastroenterology 2007, 54:1472-1476.
41. Levy L., Hill C.S. Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. Cytokine Growth F R 2006, 17:41-58.
42. Shim K.S., Kim K.H., Han W.S., Park E.B. Elevated serum levels of transforming growth factor-beta1 in patients with colorectal carcinoma: its association with tumor progression and its significant decrease after curative surgical resection. Cancer 1999, 85:554-561.
43. Qi P., Chen Y.M., Wang H., Fang M., Ji Q., Zhao Y.P., et al. 509C>T polymorphism in the TGF-beta1 gene promoter, impact on the hepatocellular carcinoma risk in chinese patients with chronic hepatitis B virus infection. Cancer Immunol Immunother 2009, 58:1433-1440.
44. Gu X., Ji X., Wang A., Gao C.F. Influence of -509C>T single-nucleotide polymorphism on the transcriptional activity of transforming growth factor-beta 1 gene in human colorectal cancer cells. Laboratory Medicine 2010, 25:678-681.